Full Name
Ross Andrew Soo
(not current staff)
Variants
Ross, S.
Soo, R.
Soo, R.-A.
Soo, R.A.
Soo, Ross
 
 
 
Email
csiras@nus.edu.sg
 

Publications

Refined By:
File Format:  Adobe PDF
Department:  PHARMACOLOGY
Subject:  Life Sciences & Biomedicine

Results 1-8 of 8 (Search time: 0.008 seconds).

Issue DateTitleAuthor(s)
117-Jun-2020Eomes Expression Defines Group 1 Innate Lymphoid Cells During Metastasis in Human and MouseVerma, Riva ; Er, Jun Zhi ; Pu, Ren Wei; Mohamed, Jameelah Sheik ; Soo, Ross A ; Muthiah, Harish Mithiran; Tam, John Kit Chung ; Ding, Jeak Ling 
2Sep-2022Factors Predictive of Primary Resistance to Immune Checkpoint Inhibitors in Asian Patients with Advanced NSCLCHuang, Y; Zhao, JJ; Soon, YY; Kee, A; Tay, SH; Aminkeng, F ; Ang, Y; Wong, A; Goh, BC; Soo, R 
312-May-2023Factors Predictive of Primary Resistance to Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung CancerHuang, Yiqing; Zhao, Joseph J; Soon, Yu Yang; Kee, Adrian; Tay, Sen Hee; Aminkeng, Folefac ; Ang, Yvonne; Wong, Alvin SC; Bharwani, Lavina D; Goh, Boon Cher; Soo, Ross A 
41-Jul-2015MEK Inhibition Overcomes Cisplatin Resistance Conferred by SOS/MAPK Pathway Activation in Squamous Cell CarcinomaKong, Li Ren ; Chua, Kian Ngiap ; Sim, Wen Jing ; Ng, Hsien Chun ; Bi, Chonglei; Ho, Jingshan ; Nga, Min En ; Pang, Yin Huei ; Ong, Weijie Richard; Soo, Ross Andrew ; Huynh, The Hung ; Chng, Wee Joo ; Thiery, Jean-Paul ; Goh, Boon Cher 
51-Jun-2022Pharmacogenomic prediction of immune-related adverse events from immune checkpoint inhibitors among Asian patientsHuang, Yiqing; Aminkeng, Folefac ; Wong, Alvin SC; Tay, Sen Hee ; Zhao, Joseph J; Ang, Yvonne; Soo, Ross A ; Goh, Boon Cher 
630-Sep-2022Real-world experience of consolidation durvalumab after concurrent chemoradiotherapy in stage III non-small cell lung cancerHuang, Yiqing; Zhao, Joseph J; Soon, Yu Yang ; Wong, Alvin; Aminkeng, Folefac ; Ang, Yvonne; Asokumaran, Yugarajah; Low, Jia Li; Lee, Matilda; Choo, Joan RE; Chan, Gloria; Kee, Adrian ; Tay, Sen Hee ; Goh, Boon Cher ; Soo, Ross A 
713-Oct-2021Risk factors for immune-related adverse events from anti-PD-1 or anti-PD-L1 treatment in an Asian cohort of nonsmall cell lung cancer patientsHuang, Yiqing; Soon, Yu Yang ; Aminkeng, Folefac ; Tay, Sen Hee ; Ang, Yvonne; Kee, Adrian CL ; Goh, Boon Cher ; Wong, Alvin SC; Soo, Ross A 
8Mar-2021Risk Factors for Immune-Related Adverse Events from Anti-PD-1/PD-L1 Treatment in an Asian Cohort of NSCLC PatientsHuang, Y; Soon, YY; Aminkeng, F ; Tay, SH; Ang, Y; Goh, BC; Wong, A; Soo, RA